MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 194 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $221,389,000 | +69519.2% | 7,278 | -39.9% | 0.02% | -4.0% |
Q1 2021 | $318,000 | +66.5% | 12,109 | +18.2% | 0.02% | +19.0% |
Q4 2020 | $191,000 | -25.7% | 10,244 | -32.4% | 0.02% | -25.0% |
Q3 2020 | $257,000 | -28.2% | 15,146 | -1.3% | 0.03% | -28.2% |
Q2 2020 | $358,000 | -2.5% | 15,353 | -50.3% | 0.04% | +25.8% |
Q2 2019 | $367,000 | +72.3% | 30,894 | +152.3% | 0.03% | +82.4% |
Q4 2018 | $213,000 | -20.5% | 12,245 | -28.9% | 0.02% | 0.0% |
Q3 2018 | $268,000 | -5.3% | 17,233 | -3.2% | 0.02% | 0.0% |
Q2 2018 | $283,000 | +53.8% | 17,794 | +38.5% | 0.02% | +70.0% |
Q3 2017 | $184,000 | +31.4% | 12,851 | +26.6% | 0.01% | +25.0% |
Q1 2017 | $140,000 | -73.2% | 10,149 | -65.7% | 0.01% | -75.8% |
Q4 2016 | $523,000 | -20.5% | 29,566 | -13.4% | 0.03% | -21.4% |
Q3 2016 | $658,000 | +7.7% | 34,131 | +8.9% | 0.04% | 0.0% |
Q2 2016 | $611,000 | -2.7% | 31,340 | +2.9% | 0.04% | -6.7% |
Q1 2016 | $628,000 | +105.2% | 30,453 | +104.5% | 0.04% | +95.7% |
Q4 2015 | $306,000 | – | 14,894 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |